A male patient is currently isolated in Prague following the onset of Ebola-like symptoms after a recent trip to the Democratic Republic of Congo.
An American man was transported to the Bulovka Hospital in Prague from Tábor in South Bohemia on Friday evening after displaying symptoms consistent with Ebola infection, necessitating comprehensive medical and emergency care.
Upon arrival, the hospital confirmed that the patient has been placed under isolation while awaiting laboratory test results.
The patient, who reportedly recently traveled to the Democratic Republic of Congo, presented with severe symptoms at a field hospital, from which he was transferred to Prague following strict protocols for biological hazards.
Bulovka Hospital is the only facility in the Czech Republic equipped to handle highly infectious diseases such as Ebola.
Health workers involved in the patient’s transport wore protective suits.
According to officials from the South Bohemian rescue service, the man was placed in a sealed transport capsule that was thoroughly disinfected, along with all personnel who came into contact with him during the care process.
Upon arrival at Bulovka, the patient was taken to the Infectious Diseases Clinic and placed in a BioBox, a hermetically sealed isolation unit specifically designed for treating patients with high-risk infectious diseases.
Prague emergency services confirmed that the “strictest precautionary measures” were implemented during the transport, in collaboration with medical teams from South Bohemia.
Eva Stolejda Libigerová, a spokesperson for the hospital, confirmed the patient’s transfer but declined to provide further details until test results are available.
The 39-year-old man, believed to be an American citizen, has a history of travel to areas previously affected by Ebola outbreaks.
Ebola virus disease is severe and often fatal, with mortality rates ranging from 25% to 90%.
The virus spreads through direct contact with infected bodily fluids or contaminated surfaces.
Symptoms include fever, vomiting, diarrhea, muscle pain, and in severe cases, internal and external bleeding.
The virus was first identified in 1976 near the Ebola River in present-day Democratic Republic of Congo, causing significant outbreaks, most notably in West Africa from 2014 to 2016, which resulted in over 11,000 deaths.
While
vaccines for Ebola have been developed in recent years, their widespread application remains limited.
Czech health officials emphasize that the country's infrastructure is prepared to respond to such cases, asserting that there is currently no threat to the public.